Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

38 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Vitamin D and Prebiotics for Intestinal Health in Cystic Fibrosis: Rationale and design for a randomized, placebo-controlled, double-blind, 2 × 2 trial of administration of prebiotics and cholecalciferol (vitamin D3) (Pre-D Trial) in adults with cystic fibrosis.
Sivapiromrat AK, Suppakitjanusant P, Wang Y, Binongo J, Hunt WR, Gewirtz A, Alvarez JA, Hu C, Weinstein S, Jathal I, Ziegler TR, Tangpricha V. Sivapiromrat AK, et al. Among authors: hunt wr. medRxiv [Preprint]. 2024 Jan 5:2024.01.04.24300860. doi: 10.1101/2024.01.04.24300860. medRxiv. 2024. PMID: 38343811 Free PMC article. Updated. Preprint.
Vitamin D and prebiotics for intestinal health in cystic fibrosis: Rationale and design for a randomized, placebo-controlled, double-blind, 2 x 2 trial of administration of prebiotics and cholecalciferol (vitamin D3) (Pre-D trial) in adults with cystic fibrosis.
Sivapiromrat AK, Suppakitjanusant P, Wang Y, Hu C, Binongo J, Hunt WR, Weinstein S, Jathal I, Alvarez JA, Chassaing B, Ziegler TR, Gewirtz AT, Tangpricha V. Sivapiromrat AK, et al. Among authors: hunt wr. Contemp Clin Trials Commun. 2024 Feb 18;38:101278. doi: 10.1016/j.conctc.2024.101278. eCollection 2024 Apr. Contemp Clin Trials Commun. 2024. PMID: 38435430 Free PMC article.
Cystic fibrosis screening, evaluation, and management of hepatobiliary disease consensus recommendations.
Sellers ZM, Assis DN, Paranjape SM, Sathe M, Bodewes F, Bowen M, Cipolli M, Debray D, Green N, Hughan KS, Hunt WR, Leey J, Ling SC, Morelli G, Peckham D, Pettit RS, Philbrick A, Stoll J, Vavrina K, Allen S, Goodwin T, Hempstead SE, Narkewicz MR. Sellers ZM, et al. Among authors: hunt wr. Hepatology. 2024 May 1;79(5):1220-1238. doi: 10.1097/HEP.0000000000000646. Epub 2023 Oct 26. Hepatology. 2024. PMID: 37934656 Free PMC article.
Author Correction: Predicting glycemic control status and high blood glucose levels through voice characteristic analysis in patients with cystic fibrosis-related diabetes (CFRD).
Suppakitjanusant P, Kasemkosin N, Sivapiromrat AK, Weinstein S, Ongphiphadhanakul B, Hunt WR, Sueblinvong V, Tangpricha V. Suppakitjanusant P, et al. Among authors: hunt wr. Sci Rep. 2023 Jul 3;13(1):10707. doi: 10.1038/s41598-023-37792-9. Sci Rep. 2023. PMID: 37400506 Free PMC article. No abstract available.
38 results